Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-synuclein overexpression increases cytosolic catecholamine concentration.

Eugene V Mosharov1, Roland G W Staal, Jordi Bové

  • 1Department of Neurology, Columbia University Medical Center, New York, New York 10032, USA.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|September 8, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered striatal dopamine regulation in Adgrl3 knockout mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Individualised mapping of living human brain mitochondria by MRI reveals signatures of bioenergetic defects.

bioRxiv : the preprint server for biology·2026
Same author

α-Synuclein and γ-Tubulin Cooperatively Regulate Activity-Evoked Presynaptic Microtubule Nucleation to Gate Dopamine Release.

bioRxiv : the preprint server for biology·2026
Same author

Modulation of WNT and FGF18 enhances yield and subtype identity of hPSC-derived midbrain dopamine neurons.

The Journal of clinical investigation·2026
Same author

Scalable workflows for high-throughput respirometry.

Life science alliance·2026
Same author

Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.

Nature·2026

Alpha-synuclein disrupts dopamine balance and vesicular pH, increasing damaging cytosolic catecholamines. This provides insight into how alpha-synuclein causes Parkinson's disease neurodegeneration.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is linked to dopamine dysregulation and catecholaminergic neuron vulnerability.
  • Mutations and overexpression of alpha-synuclein are implicated in familial forms of PD.
  • Understanding the link between alpha-synuclein and dopamine homeostasis is crucial for PD pathogenesis.

Purpose of the Study:

  • To investigate the relationship between alpha-synuclein and dopamine homeostasis.
  • To determine how different forms of alpha-synuclein affect catecholamine levels and vesicular function.
  • To elucidate the molecular mechanisms underlying alpha-synuclein-induced neurotoxicity in PD.

Main Methods:

  • Utilized transgenic mice overexpressing A30P alpha-synuclein and wild-type (WT) alpha-synuclein.

Related Experiment Videos

  • Employed intracellular patch electrochemistry to measure cytosolic catecholamine levels in chromaffin cells.
  • Assessed the impact of alpha-synuclein on ATP-dependent pH gradients in isolated chromaffin vesicles.
  • Examined L-DOPA-treated PC12 cells overexpressing different alpha-synuclein variants.

    • Main Results:

    • Overexpression of A30P alpha-synuclein significantly increased cytosolic catecholamine levels in chromaffin cells.
    • Both A30P and A53T alpha-synuclein overexpression inhibited the ability of cells to maintain low cytosolic dopamine levels after L-DOPA challenge.
    • WT, A30P, and A53T alpha-synuclein inhibited ATP-dependent maintenance of pH gradients in chromaffin vesicles, with WT being less potent.
    • Alpha-synuclein overexpression disrupts vesicular pH and elevates cytosolic catechol species, potentially leading to oxidative damage.

    Conclusions:

    • Alpha-synuclein overexpression disrupts catecholamine homeostasis and vesicular function.
    • Elevated cytosolic catecholamines due to alpha-synuclein may trigger cellular oxidative damage, contributing to PD pathogenesis.
    • This study provides critical evidence for alpha-synuclein's role in the selective damage of catecholaminergic cells in Parkinson's disease.